BRPI0913586A8 - combinação, e, uso de uma combinação. - Google Patents

combinação, e, uso de uma combinação.

Info

Publication number
BRPI0913586A8
BRPI0913586A8 BRPI0913586A BRPI0913586A BRPI0913586A8 BR PI0913586 A8 BRPI0913586 A8 BR PI0913586A8 BR PI0913586 A BRPI0913586 A BR PI0913586A BR PI0913586 A BRPI0913586 A BR PI0913586A BR PI0913586 A8 BRPI0913586 A8 BR PI0913586A8
Authority
BR
Brazil
Prior art keywords
combination
Prior art date
Application number
BRPI0913586A
Other languages
English (en)
Inventor
Celestino Fernandes Antonio
Elizabeth Medlen Constance
Leivers Stephen
Original Assignee
Pfeinsmith Ltd
Pfeinsmith S A Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfeinsmith Ltd, Pfeinsmith S A Pty Ltd filed Critical Pfeinsmith Ltd
Publication of BRPI0913586A2 publication Critical patent/BRPI0913586A2/pt
Publication of BRPI0913586A8 publication Critical patent/BRPI0913586A8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A61K31/431—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems containing further heterocyclic rings, e.g. ticarcillin, azlocillin, oxacillin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
BRPI0913586A 2008-06-05 2009-06-04 combinação, e, uso de uma combinação. BRPI0913586A8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ZA200804901 2008-06-05
PCT/IB2009/052366 WO2009147635A1 (en) 2008-06-05 2009-06-04 Fulvic acid and antibiotic combination

Publications (2)

Publication Number Publication Date
BRPI0913586A2 BRPI0913586A2 (pt) 2015-10-27
BRPI0913586A8 true BRPI0913586A8 (pt) 2018-03-13

Family

ID=40887008

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0913586A BRPI0913586A8 (pt) 2008-06-05 2009-06-04 combinação, e, uso de uma combinação.

Country Status (8)

Country Link
US (1) US8445452B2 (pt)
EP (1) EP2317998B1 (pt)
CN (1) CN102099027B (pt)
BR (1) BRPI0913586A8 (pt)
PL (1) PL2317998T3 (pt)
RU (1) RU2505295C2 (pt)
WO (1) WO2009147635A1 (pt)
ZA (1) ZA201008680B (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0914966D0 (en) * 2009-08-27 2009-09-30 Natracine Uk Ltd Fulvic acid compositions and their use
KR20140135813A (ko) 2012-03-07 2014-11-26 나트라신 유케이 리미티드 다제 내성 박테리아의 억제 또는 치료를 위한 풀브산과 항생제 조합
CN113813304A (zh) * 2020-06-18 2021-12-21 陈信行 腐植酸山苍子复方及其制程
CN111616358A (zh) * 2020-06-20 2020-09-04 田劭军 一种用于提高免疫力的组合物及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5204368A (en) * 1990-05-25 1993-04-20 National Energy Council Bacteriostatic and bacteriocidal method using fulvic acid derivatives
ATE410160T1 (de) * 1998-10-08 2008-10-15 Pfeinsmith Ltd Fulvinsäure und deren verwendung in der behandlung von entzündungen
CN1120820C (zh) 1999-08-12 2003-09-10 河南省科学院生物研究所 健植液肥
CN101437509B (zh) 2006-05-02 2012-03-14 皮费恩史密斯有限公司 酸性组合物
CN101129382B (zh) 2006-08-25 2013-12-25 天津和美生物技术有限公司 含β-内酰胺类抗生素和缓冲组分的抗生素复方

Also Published As

Publication number Publication date
US8445452B2 (en) 2013-05-21
US20110207687A1 (en) 2011-08-25
CN102099027B (zh) 2012-12-12
ZA201008680B (en) 2012-03-28
RU2010154511A (ru) 2012-07-20
BRPI0913586A2 (pt) 2015-10-27
EP2317998A1 (en) 2011-05-11
WO2009147635A1 (en) 2009-12-10
PL2317998T3 (pl) 2016-11-30
RU2505295C2 (ru) 2014-01-27
CN102099027A (zh) 2011-06-15
EP2317998B1 (en) 2016-04-20

Similar Documents

Publication Publication Date Title
BRPI0908792A2 (pt) Composição, e, uso de uma combinação
NO2021006I1 (no) Quofenix, delafloksacin
BRPI0813770A2 (pt) Composição, e, uso de uma composição
BR112012002349A2 (pt) composto,e, uso do mesmo
BRPI0813235A2 (pt) Combinação anti-helmíntica.
BRPI0909770A2 (pt) Vacina, e, kit
BRPI1007018A2 (pt) composto, composição farmacêutica, e , uso de um composto.
BRPI1014316A2 (pt) composição, e, uso de uma composição
BR112012004335A2 (pt) composto, composição farmacêutica, e, uso do composto.
BRPI0914793A2 (pt) Composição, e, uso de uma composição
BRPI0915134A2 (pt) composto, e, uso de um composto
BRPI0807473A2 (pt) Recipiente, javre e conjunto de recipiente e javre
BRPI0823082A2 (pt) Uso derivados de sesquiterpeno
BRPI1016117A2 (pt) derivados de isoxazol-isoxazol e isoxasol-isotiazol.
BR112013003536A2 (pt) composição, e utilização de uma composição.
BRPI0919216A2 (pt) poliuretano, e, uso de um poliuretano
IT1396406B1 (it) Stantuffo.
BRPI0917446A2 (pt) derivados de acilaminobenzamida.
BRPI0913175A2 (pt) artigo antibalístico, e, uso do mesmo.
BRPI0922070A2 (pt) turbina.
BRPI0916575A2 (pt) composição de graxa lubrificante, e, uso de uma composição de graxa lubrificante
BRPI0907448A2 (pt) Instrumentos.
BRPI0911772A2 (pt) composto, composição farmacêutica, e, uso do composto.
BRPI0917016A2 (pt) composição lubrificante, e, uso de uma composição lubrificante
BRPI1009763A2 (pt) composição, e , uso de um composto.

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: PFEINSMITH LTD (ZA)

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements